Connection

James Bearden to Patient Reported Outcome Measures

Back to Details
This is a "connection" page, showing publications James Bearden has written about Patient Reported Outcome Measures.
James Bearden
Connection Strength
0.032
Patient Reported Outcome Measures
  1. Repeated measures analyses of dermatitis symptom evolution in breast cancer patients receiving radiotherapy in a phase 3 randomized trial of mometasone furoate vs placebo (N06C4 [alliance]). Support Care Cancer. 2016 09; 24(9):3847-55.
    View in: PubMed
    Score: 0.032
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.